Background: When left ventricular assist device (LVAD) therapy no longer is able to achieve
patients' desired quality of life, withdrawal of LVAD therapy (WLVAD) may be requested …

The increased use of left ventricular assist devices (LVADs) is expected, particularly as
destination therapy for patients with advanced heart failure who are not transplant …

Background: The optimal level of palliative care (PC) involvement in left ventricular assist
device (LVAD) therapy has yet to be determined. Objective: Describe the feasibility of PC …

Background: The difference of end-of-life care for left ventricular assist device (LVAD)
patients, between destination therapy (DT) and bridge to transplant (BTT), and the effect of …

Background—Despite the ability of left ventricular assist device as destination therapy (DT-
LVAD) to prolong survival for many patients with advanced heart failure, little is known about …

Background Beliefs around deactivation of a left ventricular assist device (LVAD) vary
substantially among clinicians, institutions, and patients. Therefore, we sought to understand …

Aims Left ventricular assist devices (LVADs) are implanted to support the circulation of
patients with advanced heart failure. Patients approaching death, or their surrogates, may …

Left ventricular assist devices (LVAD) are increasingly being used to treat end-stage heart
failure. Despite the increased prevalence of these devices, there is a still a high 1-year …

Background: Left ventricular assist devices (LVADs) are a relatively new technology that is
increasingly used to preserve cardiac function. These devices work by a mechanism that …

Background Repeat hospitalizations, complications, and psychosocial burdens are common
in patients with left ventricular assist devices (LVAD). Specialist palliative care (sPC) …